(Q41114237)

26 September 2017

1 reference

title

Efficacy of hemostatic agents in improving surgical hemostasis (English)

1 reference

26 September 2017

Green D

1

1 reference

26 September 2017

Wong CA

series ordinal

2

1 reference

26 September 2017

Twardowski P

series ordinal

3

1 reference

26 September 2017

publication date

1 July 1996

1 reference

Transfusion Medicine Reviews

26 September 2017

published in

1 reference

26 September 2017

volume

10

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

171-182

1 reference

Fibrin glue in cardiothoracic surgery.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

The preparation of fibrinogen concentrate for use as fibrin glue by four different methods

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Intraoperative procurement of autologous fibrin glue

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Aortic valve repair with fibrin glue for type A acute aortic dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Rapid polymerizing fibrin glue from autologous or single-donor blood: preparation and indications

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Fibrin glue sealing of pancreatic injuries, resections, and anastomoses

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Dental extractions in patients with bleeding disorders. The use of fibrin glue

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin and antifibrinolytics.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin (DDAVP) and hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Use of DDAVP in inherited and acquired platelet dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hand surgery in Glanzmann's thrombasthenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Use of desmopressin to prevent bleeding complications in patients treated with aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Pro: Desmopressin is of value in the treatment of post-cardiopulmonary bypass bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin and blood loss after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin Decreases Operative Blood Loss in Spinal Cord Injury Patients Having Flap Reconstruction of Pelvic Pressure Sores

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

1 reference

7 January 2021

Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbit and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Plasmin generation and fibrin(ogen)olysis following desmopressin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Lamotrigine versus carbamazepine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Intraoperative cerebral infarction after desmopressin administration in infant with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hypersensitivity to chlorobutanol in DDAVP solution

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Herpes simplex type 2 virus encephalitis presenting as psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Recombinant aprotinin in coronary artery bypass graft operations.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Relationship of platelet aggregation to bleeding after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Reversal of streptokinase-induced bleeding with aprotinin for emergency cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Aprotinin reduces the need for blood products during liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Effect of tranexamic acid on platelet ADP during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

The dose-response relationship of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Tranexamic acid significantly reduces blood loss associated with coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Prophylactic treatment of postperfusion bleeding using EACA.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

DDAVP and EACA used for minor oral surgery in von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Comparison of epsilon aminocaproic acid and normal saline for postoperative bladder irrigation following transurethral resection of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Management of subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Microscopic haematuria as a relative contraindication for tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

Hemodynamic responses to desmopressin acetate after CABG: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980058-7

7 January 2021

10.1016/S0887-7963(96)80058-7

Identifiers

DOI

1 reference

26 September 2017

1 reference